Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

10.0%

1 terminated/withdrawn out of 10 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

200%

2 of 1 completed trials have results

Key Signals

5 recruiting2 with results

Enrollment Performance

Analytics

N/A

8(88.9%)

Phase 4

1(11.1%)

9Total

N/A(8)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT07015957Phase 4Recruiting

Kupewa: Optimizing Implementation Strategies for Cervical Cancer Prevention

Role: collaborator

NCT07221747Not ApplicableRecruiting

PathToScale: The PERSIST Trial

Role: collaborator

NCT07329166Not ApplicableRecruiting

Reducing Mobility-associated Interruption in HIV Treatment in Malawi

Role: collaborator

NCT07220278Not ApplicableRecruiting

Ongoing Dynamic Choice to Address HIV Treatment Interruption in Malawi

Role: collaborator

NCT06319105Recruiting

PathToScale: An Implementation Evaluation

Role: collaborator

NCT05137210Not ApplicableUnknown

Identifying Efficient Linkage Strategies for Men

Role: collaborator

NCT04878601Not ApplicableUnknown

Innovative Strategies to Increase ART Initiation and Viral Suppression Among HIV-positive Men in Malawi

Role: collaborator

NCT04858243Not ApplicableUnknown

Engaging Men Through HIV Self-Testing With Differentiated Care to Improve ART Initiation and Viral Suppression Among Men in Malawi

Role: collaborator

NCT03271307Not ApplicableCompleted

Use of HIV Self-Test Kits to Increase Identification of HIV-Infected Individuals and Their Partners

Role: collaborator

NCT03101592Not ApplicableTerminated

INTERVAL: Varying Intervals of ART to Improve Outcomes in HIV

Role: collaborator

All 10 trials loaded